title: Canine immune-mediated hemolytic anemia: treatment and prognosis.
abstract: The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.
authors.affiliation: Las Vegas Veterinary Referral Center, USA.
authors.forename: Andrea
authors.initials: A
authors.lastname: Balch
authors.forename: Andrew
authors.initials: A
authors.lastname: Mackin
mesh_terms: D000367:Age Factors; D000744:Anemia, Hemolytic, Autoimmune / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D000818:Animals; D001803:Blood Transfusion / Q000662:veterinary*; D004283:Dog Diseases / Q000473:pathology* / Q000628:therapy*; D004285:Dogs; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D013156:Splenectomy / Q000662:veterinary*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents